nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Brimonidine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Brimonidine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Brimonidine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00122	0.00122	CcSEcCtD
Brimonidine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00122	CcSEcCtD
Brimonidine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Brimonidine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Brimonidine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Brimonidine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Brimonidine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Brimonidine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Brimonidine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Brimonidine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Brimonidine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Brimonidine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Brimonidine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Brimonidine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Brimonidine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Brimonidine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Brimonidine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Brimonidine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Brimonidine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Brimonidine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Brimonidine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Brimonidine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Brimonidine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Brimonidine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Brimonidine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.00115	CcSEcCtD
Brimonidine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Brimonidine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Brimonidine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Brimonidine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Brimonidine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Brimonidine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Brimonidine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Brimonidine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Brimonidine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Brimonidine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Brimonidine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Brimonidine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Brimonidine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Brimonidine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Brimonidine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Brimonidine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Brimonidine—Headache—Didanosine—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Brimonidine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Brimonidine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Brimonidine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Brimonidine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Brimonidine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Brimonidine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Brimonidine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Brimonidine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Brimonidine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Brimonidine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Brimonidine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Brimonidine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Brimonidine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Brimonidine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Brimonidine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Brimonidine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Brimonidine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Brimonidine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Brimonidine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Brimonidine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Brimonidine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Brimonidine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Brimonidine—Pain—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Brimonidine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Brimonidine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Brimonidine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Brimonidine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Brimonidine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Brimonidine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Brimonidine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Brimonidine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Brimonidine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Brimonidine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Brimonidine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Brimonidine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Brimonidine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Brimonidine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Brimonidine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Brimonidine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Brimonidine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Brimonidine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Brimonidine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Brimonidine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Brimonidine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Brimonidine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000995	0.000995	CcSEcCtD
Brimonidine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000995	0.000995	CcSEcCtD
Brimonidine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000994	0.000994	CcSEcCtD
Brimonidine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000993	0.000993	CcSEcCtD
Brimonidine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000992	0.000992	CcSEcCtD
Brimonidine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000991	0.000991	CcSEcCtD
Brimonidine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00099	0.00099	CcSEcCtD
Brimonidine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000989	0.000989	CcSEcCtD
Brimonidine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000986	0.000986	CcSEcCtD
Brimonidine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000986	0.000986	CcSEcCtD
Brimonidine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000986	0.000986	CcSEcCtD
Brimonidine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000984	0.000984	CcSEcCtD
Brimonidine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000983	0.000983	CcSEcCtD
Brimonidine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00098	0.00098	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000979	0.000979	CcSEcCtD
Brimonidine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000975	0.000975	CcSEcCtD
Brimonidine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000974	0.000974	CcSEcCtD
Brimonidine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000972	0.000972	CcSEcCtD
Brimonidine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000964	0.000964	CcSEcCtD
Brimonidine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000964	0.000964	CcSEcCtD
Brimonidine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000963	0.000963	CcSEcCtD
Brimonidine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000962	0.000962	CcSEcCtD
Brimonidine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000962	0.000962	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000961	0.000961	CcSEcCtD
Brimonidine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000961	0.000961	CcSEcCtD
Brimonidine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00096	0.00096	CcSEcCtD
Brimonidine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00096	0.00096	CcSEcCtD
Brimonidine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000957	0.000957	CcSEcCtD
Brimonidine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000954	0.000954	CcSEcCtD
Brimonidine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000952	0.000952	CcSEcCtD
Brimonidine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00095	0.00095	CcSEcCtD
Brimonidine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000946	0.000946	CcSEcCtD
Brimonidine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000945	0.000945	CcSEcCtD
Brimonidine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000945	0.000945	CcSEcCtD
Brimonidine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00094	0.00094	CcSEcCtD
Brimonidine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000939	0.000939	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000938	0.000938	CcSEcCtD
Brimonidine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000937	0.000937	CcSEcCtD
Brimonidine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000937	0.000937	CcSEcCtD
Brimonidine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000931	0.000931	CcSEcCtD
Brimonidine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00093	0.00093	CcSEcCtD
Brimonidine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000927	0.000927	CcSEcCtD
Brimonidine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000926	0.000926	CcSEcCtD
Brimonidine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000924	0.000924	CcSEcCtD
Brimonidine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000918	0.000918	CcSEcCtD
Brimonidine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000918	0.000918	CcSEcCtD
Brimonidine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000915	0.000915	CcSEcCtD
Brimonidine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000908	0.000908	CcSEcCtD
Brimonidine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000907	0.000907	CcSEcCtD
Brimonidine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000906	0.000906	CcSEcCtD
Brimonidine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000905	0.000905	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000903	0.000903	CcSEcCtD
Brimonidine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000896	0.000896	CcSEcCtD
Brimonidine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000891	0.000891	CcSEcCtD
Brimonidine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00089	0.00089	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000889	0.000889	CcSEcCtD
Brimonidine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000888	0.000888	CcSEcCtD
Brimonidine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000884	0.000884	CcSEcCtD
Brimonidine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000883	0.000883	CcSEcCtD
Brimonidine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000883	0.000883	CcSEcCtD
Brimonidine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000881	0.000881	CcSEcCtD
Brimonidine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00088	0.00088	CcSEcCtD
Brimonidine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000876	0.000876	CcSEcCtD
Brimonidine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000872	0.000872	CcSEcCtD
Brimonidine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000871	0.000871	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000861	0.000861	CcSEcCtD
Brimonidine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000857	0.000857	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000855	0.000855	CcSEcCtD
Brimonidine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000855	0.000855	CcSEcCtD
Brimonidine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000854	0.000854	CcSEcCtD
Brimonidine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000849	0.000849	CcSEcCtD
Brimonidine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000847	0.000847	CcSEcCtD
Brimonidine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000843	0.000843	CcSEcCtD
Brimonidine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00084	0.00084	CcSEcCtD
Brimonidine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000835	0.000835	CcSEcCtD
Brimonidine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000835	0.000835	CcSEcCtD
Brimonidine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000834	0.000834	CcSEcCtD
Brimonidine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000832	0.000832	CcSEcCtD
Brimonidine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00083	0.00083	CcSEcCtD
Brimonidine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000823	0.000823	CcSEcCtD
Brimonidine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00082	0.00082	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000816	0.000816	CcSEcCtD
Brimonidine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000815	0.000815	CcSEcCtD
Brimonidine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000814	0.000814	CcSEcCtD
Brimonidine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000808	0.000808	CcSEcCtD
Brimonidine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000799	0.000799	CcSEcCtD
Brimonidine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000788	0.000788	CcSEcCtD
Brimonidine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000787	0.000787	CcSEcCtD
Brimonidine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000776	0.000776	CcSEcCtD
Brimonidine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000776	0.000776	CcSEcCtD
Brimonidine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000771	0.000771	CcSEcCtD
Brimonidine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000769	0.000769	CcSEcCtD
Brimonidine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000758	0.000758	CcSEcCtD
Brimonidine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000739	0.000739	CcSEcCtD
Brimonidine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000736	0.000736	CcSEcCtD
Brimonidine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000734	0.000734	CcSEcCtD
Brimonidine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000733	0.000733	CcSEcCtD
Brimonidine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000732	0.000732	CcSEcCtD
Brimonidine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00073	0.00073	CcSEcCtD
Brimonidine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000729	0.000729	CcSEcCtD
Brimonidine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000728	0.000728	CcSEcCtD
Brimonidine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000711	0.000711	CcSEcCtD
Brimonidine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000702	0.000702	CcSEcCtD
Brimonidine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000701	0.000701	CcSEcCtD
Brimonidine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000701	0.000701	CcSEcCtD
Brimonidine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000697	0.000697	CcSEcCtD
Brimonidine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000696	0.000696	CcSEcCtD
Brimonidine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000691	0.000691	CcSEcCtD
Brimonidine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000681	0.000681	CcSEcCtD
Brimonidine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000678	0.000678	CcSEcCtD
Brimonidine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000669	0.000669	CcSEcCtD
Brimonidine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000661	0.000661	CcSEcCtD
Brimonidine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000655	0.000655	CcSEcCtD
Brimonidine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000649	0.000649	CcSEcCtD
Brimonidine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000649	0.000649	CcSEcCtD
Brimonidine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000645	0.000645	CcSEcCtD
Brimonidine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000625	0.000625	CcSEcCtD
Brimonidine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000625	0.000625	CcSEcCtD
Brimonidine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000624	0.000624	CcSEcCtD
Brimonidine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000621	0.000621	CcSEcCtD
Brimonidine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000612	0.000612	CcSEcCtD
Brimonidine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000596	0.000596	CcSEcCtD
Brimonidine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000595	0.000595	CcSEcCtD
Brimonidine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000592	0.000592	CcSEcCtD
Brimonidine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000589	0.000589	CcSEcCtD
Brimonidine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000561	0.000561	CcSEcCtD
